CII
ELV icon

Capital International Inc’s Elevance Health ELV Stock Holding History

Capital International Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95M Hold
20,557
– – 0.06% 209
2026
Q1 		$6.02M Buy
20,557
+1,628
+9% +$535K 0.05% 222
2025
Q4 		$6.64M Sell
18,929
-31,998
-63% -$10.8M 0.05% 231
2025
Q3 		$16.5M Sell
50,927
-27,801
-35% -$8.65M 0.13% 167
2025
Q2 		$30.6M Buy
78,728
+24,176
+44% +$9.72M 0.3% 91
2025
Q1 		$23.7M Buy
54,552
+10,163
+23% +$4.08M 0.29% 98
2024
Q4 		$16.4M Buy
44,389
+6,104
+16% +$2.55M 0.19% 130
2024
Q3 		$19.9M Buy
38,285
+1,365
+4% +$729K 0.25% 109
2024
Q2 		$20M Buy
36,920
+1,328
+4% +$702K 0.27% 104
2024
Q1 		$18.5M Buy
35,592
+2,960
+9% +$1.47M 0.25% 115
2023
Q4 		$15.4M Buy
32,632
+4,709
+17% +$2.18M 0.24% 120
2023
Q3 		$12.2M Sell
27,923
-10,693
-28% -$4.85M 0.23% 123
2023
Q2 		$17.2M Buy
38,616
+3,175
+9% +$1.46M 0.31% 96
2023
Q1 		$16.3M Sell
35,441
-872
-2% -$415K 0.33% 93
2022
Q4 		$18.6M Buy
36,313
+278
+0.8% +$141K 0.4% 78
2022
Q3 		$16.4M Sell
36,035
-48,761
-58% -$23.3M 0.37% 84
2022
Q2 		$40.9M Sell
84,796
-6,476
-7% -$3.2M 0.57% 59
2022
Q1 		$44.8M Sell
91,272
-4,185
-4% -$1.91M 0.5% 73
2021
Q4 		$44.2M Sell
95,457
-698
-0.7% -$294K 0.41% 81
2021
Q3 		$35.8M Sell
96,155
-14,115
-13% -$5.36M 0.35% 93
2021
Q2 		$42.1M Sell
110,270
-8,721
-7% -$3.33M 0.38% 95
2021
Q1 		$42.7M Sell
118,991
-12,990
-10% -$4.18M 0.4% 89
2020
Q4 		$42.4M Sell
131,981
-465
-0.4% -$143K 0.39% 94
2020
Q3 		$35.6M Sell
132,446
-16,249
-11% -$4.37M 0.39% 93
2020
Q2 		$39.1M Buy
148,695
+2,644
+2% +$705K 0.48% 77
2020
Q1 		$33.2M Buy
146,051
+3,524
+2% +$960K 0.56% 71
2019
Q4 		$43M Buy
142,527
+12,960
+10% +$3.57M 0.6% 75
2019
Q3 		$31.1M Buy
129,567
+126,730
+4,467% +$34.7M 0.47% 89
2019
Q2 		$801K Buy
+2,837
New +$775K 0.06% 166

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Inc's ELV Position: Q2 2026 in Review

Capital International Inc held its Elevance Health (ELV) position steady in Q2 2026 at 20,557 shares worth $7.95M. The position accounts for 0.06% of the portfolio, ranked #209.

Capital International Inc first reported a position in ELV in Q2 2019 and has held it in 29 quarters since. The position peaked at $44.8M in Q1 2022. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capital International Inc held 20,557 shares of Elevance Health worth $7.95M as of Q2 2026.
  • Capital International Inc left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.06% of Capital International Inc's portfolio in Q2 2026, its #209 holding.
  • Capital International Inc first reported a position in Elevance Health in Q2 2019 and has held it in 29 quarters since.
  • Capital International Inc's Elevance Health position peaked at $44.8M in Q1 2022.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.